Education
About Us
Working with TipRanks
Follow Us
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 130.09B | ¥ 119.53B | ¥ 113.27B | ¥ 105.53B | ¥ 102.90B |
| Gross Profit | ¥ 59.51B | ¥ 51.41B | ¥ 50.17B | ¥ 49.44B | ¥ 51.63B |
| Operating Income | ¥ 12.55B | ¥ 6.23B | ¥ 5.12B | ¥ 5.01B | ¥ 5.79B |
| EBITDA | ¥ 17.55B | ¥ 11.37B | ¥ 10.81B | ¥ 8.72B | ¥ 11.98B |
| Net Income | ¥ 9.09B | ¥ 5.47B | ¥ 4.72B | ¥ 3.93B | ¥ 6.13B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 16.51B | ¥ 13.98B | ¥ 19.39B | ¥ 27.49B | ¥ 30.84B |
| Total Assets | ¥ 193.62B | ¥ 177.68B | ¥ 176.04B | ¥ 171.92B | ¥ 167.13B |
| Total Debt | ¥ 28.44B | ¥ 20.95B | ¥ 21.28B | ¥ 21.62B | ¥ 21.88B |
| Net Debt | ¥ 13.42B | ¥ 7.06B | ¥ 1.88B | ¥ -5.37B | ¥ -5.56B |
| Total Liabilities | ¥ 57.33B | ¥ 46.90B | ¥ 50.59B | ¥ 47.42B | ¥ 42.47B |
| Stockholders' Equity | ¥ 136.28B | ¥ 130.78B | ¥ 125.46B | ¥ 124.51B | ¥ 124.66B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -2.19B | ¥ -4.70B | ¥ -7.40B | ¥ 3.66B | ¥ 65.00M |
| Operating Cash Flow | ¥ 3.51B | ¥ 1.55B | ¥ 2.01B | ¥ 6.35B | ¥ 5.19B |
| Investing Cash Flow | ¥ -6.32B | ¥ -3.19B | ¥ -6.28B | ¥ -2.56B | ¥ -4.26B |
| Financing Cash Flow | ¥ 3.95B | ¥ -3.35B | ¥ -3.36B | ¥ -4.11B | ¥ -4.92B |